Rhythm Pharmaceuticals GAAP EPS of -$0.73 beats by $0.07, revenue of $57.3M beats by $1.09M

Rhythm Pharmaceuticals reported GAAP EPS of -$0.73, beating estimates, and revenue of $57.3 million, which also surpassed expectations.